# Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia

> **NCT02154503** · PHASE1 · UNKNOWN · sponsor: **Vancouver General Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Androgenetic Alopecia

## Interventions

- **DEVICE:** topical 5% Minoxidil (Microneedling)

## Key facts

- **NCT ID:** NCT02154503
- **Lead sponsor:** Vancouver General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2014-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02154503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02154503, "Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02154503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*